Maternal hyperphenylalaninemia fetal effects

Area of Science:

• Biochemistry
• Teratology
• Genetics

Background:

• Untreated maternal hyperphenylalaninemia is a known risk factor for fetal development.
• Understanding the teratogenic effects of phenylalanine is crucial for prenatal care.

Purpose of the Study:

• To investigate the pattern of malformations in offspring exposed to maternal hyperphenylalaninemia.
• To assess the teratogenic potential of maternal hyperphenylalaninemia and its correlation with phenylalanine levels.

Main Methods:

• Observational study of 34 children born to 11 mothers with untreated hyperphenylalaninemia.
• Clinical evaluation of malformations, growth, and neurological function in offspring.
• Correlation analysis between maternal blood phenylalanine concentrations and observed teratogenic effects.

Main Results:

• Offspring exhibited significant prenatal and postnatal growth retardation.
• Microcephaly and central nervous system dysfunction were prevalent.
• A higher incidence of malformations and a characteristic facial appearance were noted in the children.
• Teratogenic effects showed variability linked to maternal phenylalanine blood concentrations.

Conclusions:

• Maternal hyperphenylalaninemia is a significant teratogen, posing risks to fetal development.
• The severity of developmental abnormalities is associated with maternal phenylalanine levels.
• This highlights the importance of managing hyperphenylalaninemia during pregnancy to prevent adverse outcomes.